BlackRock Health Sciences Trust (BME) to Issue Monthly Dividend of $0.26 on March 31st

BlackRock Health Sciences Trust (NYSE:BME) declared a monthly dividend on Friday, January 2nd. Investors of record on Friday, March 13th will be given a dividend of 0.2621 per share on Tuesday, March 31st. This represents a c) dividend on an annualized basis and a dividend yield of 7.7%. The ex-dividend date is Friday, March 13th.

BlackRock Health Sciences Trust Trading Down 0.6%

BlackRock Health Sciences Trust stock traded down $0.25 during mid-day trading on Wednesday, hitting $40.67. The stock had a trading volume of 5,809 shares, compared to its average volume of 39,321. BlackRock Health Sciences Trust has a one year low of $34.18 and a one year high of $42.74. The firm’s 50 day moving average is $41.86 and its 200 day moving average is $39.81.

Institutional Trading of BlackRock Health Sciences Trust

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Northwestern Mutual Wealth Management Co. boosted its stake in BlackRock Health Sciences Trust by 285,436.7% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 4,046,055 shares of the company’s stock worth $166,414,000 after purchasing an additional 4,044,638 shares during the period. 1607 Capital Partners LLC lifted its holdings in shares of BlackRock Health Sciences Trust by 49.5% in the fourth quarter. 1607 Capital Partners LLC now owns 229,260 shares of the company’s stock worth $9,429,000 after buying an additional 75,958 shares in the last quarter. Invesco Ltd. boosted its position in shares of BlackRock Health Sciences Trust by 7.6% during the third quarter. Invesco Ltd. now owns 217,169 shares of the company’s stock worth $8,085,000 after acquiring an additional 15,381 shares during the last quarter. Bank of America Corp DE grew its stake in BlackRock Health Sciences Trust by 18.8% during the third quarter. Bank of America Corp DE now owns 216,404 shares of the company’s stock valued at $8,057,000 after acquiring an additional 34,218 shares in the last quarter. Finally, Royal Bank of Canada grew its stake in BlackRock Health Sciences Trust by 13.0% during the fourth quarter. Royal Bank of Canada now owns 160,464 shares of the company’s stock valued at $6,600,000 after acquiring an additional 18,442 shares in the last quarter.

About BlackRock Health Sciences Trust

BlackRock Health Sciences Trust (NYSE: BME) is a closed-end management investment company that seeks long-term total return through a combination of dividend income and capital appreciation. Managed by BlackRock Fund Advisors, the trust invests primarily in the equity securities of domestic and international issuers engaged in the health sciences sector. The portfolio typically includes common stocks, corporate bonds and convertible securities of companies involved in biotechnology, pharmaceuticals, medical devices and healthcare services.